Abstract
Serum carboxypeptidase N (SCPN) is the primary inactivator of the C3a, C4a, and C5a anaphylatoxins as well as an inactivator of bradykinin. Thus SCPN deficiency potentially could result in significant pathophysiologic consequences. Previous studies identified a deficient subject afflicted with frequent episodes of angioedema, and other family members also had SCPN deficiency. To delineate this abnormality further, the fractional catabolic rate (FRC) and enzyme synthesis were determined in three members of the afflicted kindred as well as in five normal persons following the infusion of homogeneous125I-SCPN. The mean FCR and synthesis rates for SCPN in the normal subjects were 1.3%/hr and 20,793 U/kg/hr, respectively. Reduced synthesis was concluded to be primarily responsible for the low SCPN levels in the afflicted kindred. The high FRC of SCPN discourages attempted maintenance therapy with infusions of enriched SCPN preparations.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Mathews KP, Pan PM, Gardner NJ, Hugli TE: Familial carboxypeptidase N deficiency. Ann Intern Med 93:443–445, 1980
Plummer TH, Hurwitz MY: Human plasma carboxypeptidase N; Isolation and characterization. J Biol Chem 253:3907–3912, 1978
Corbin NC, Hugli TE, Muller-Eberhard HJ: Serum carboxypeptidase B: A spectrophotometric assay using protamine as substrate. Anal Biochem 73:41–51, 1976
Nosslin B: Analysis of disappearance time-curves after single injection of labelled proteins.In Protein Turnover, a Ciba Symposium. New York, Associated Scientific, 1973, pp 113–130
Campbell RM, Cuthbertson DP, Matthews CME, McFarlane AS: Behaviour of14C- and131I-labelled plasma proteins in the rat. Int J Appl Radiat Isol 1:66–84, 1956
Matthews CME: Radioisotope techniques in the study of protein metabolism. Int Atom Energy Agency Tech Rep Ser 45:105–118, 1965
Krick EH, DeHeer DH, Kaplan RA, Arroyave CM, Vaughan JH: Metabolism of factor B of serum complement in rheumatoid arthritis. Clin Exp Immunol 34:1–9, 1978
Erdos E, Wohler IM, Levine MI, Westerman MP: Carboxypeptidase in blood and other fluids: Values in human blood in normal and pathological conditions. Clin Chim Acta 11:39–43, 1965
Bokisch VA, Muller-Eberhard HJ: Anaphylatoxin inactivator of human plasma: Its isolation and characterization as a carboxypeptidase. J Clin Invest 49:2427–2436, 1970
McCormick JR, Kreutzer DL, Keating HJ, Hupp J, Despins A, Moore M: Alterations in activities of anaphylatoxin inactivator and chemotactic factor inactivator during hemodialysis. Am J Pathol 109:283–287, 1982
Skidgel RA, Johnson AR, Erdos EG: Hydrolysis of opoid hexapeptides by carboxypeptidase N. Presence of carboxypeptidase in cell membranes. Biochem Pharmacol 33:3471–3478, 1984
Ryan JW, Ryan US: A radioassay for carboxypeptidase N. Adv Exp Med Biol 156 (Pt B):867–874, 1983
Stimler NP, Brocklehurst WE, Bloor CM, Hugli TE: Anaphylatoxin-mediated contraction of guinea pig lung strips: A nonhistamine tissue response. J Immunol 126:2258–2261, 1981
Stimler NP, Hugli TE, Bloor CM: Pulmonary injury induced by C3a and C5a anaphylatoxins. Am J Pathol 100:327–348, 1980
Gerard C, Hugli TE: C5a: A mediator of chemotaxis and cellular release reactions.In Biochemistry of the Acute Allergic Reactions, Kroc Foundation Series, Vol 14, EL Becker, AS Simons, KF Austen (eds). New York, Alan R. Liss, 1981, pp 147–160
Huey R, Bloor CM, Kawahara MS, Hugli TE: Potentiation of the anaphylatoxins in vivo using an inhibitor of serum carboxypeptidase N (SCPN). I. Lethality and pathologic effects on pulmonary tissue. Am J Pathol 112:48–60, 1983
Koheil A, Forstner G: Isoelectric focusing of carboxypeptidase N. Biochem Biophys Acta 524:156–161, 1978
Quastel M, Harrison R, Cicardi M, Alper CA, Rosen FS: Behavior in vivo of normal dysfunctional C1 inhibitor in normal subjects and patients with hereditary angioneurotic edema. J Clin Invest 71:1041–1046, 1983
Gadek JE, Hosea SW, Gelfand JA, Santella M, Wickerhauser M, Triantaphyllopoulos DC, Frank MM: Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor. N Engl J Med 302:542–546, 1980
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mathews, K.P., Curd, J.G. & Hugli, T.E. Decreased synthesis of serum carboxypeptidase N (SCPN) in familial SCPN deficiency. J Clin Immunol 6, 87–91 (1986). https://doi.org/10.1007/BF00915368
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00915368